Travere Therapeutics TVTX
NASDAQ TVTX
$52.04 +0.05 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

Travere Therapeutics (TVTX) Capital Expenditures (2012 - 2025)

Updated

Analysis

Travere Therapeutics (TVTX) Capital Expenditures (2012 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Travere Therapeutics 4.97 Bn 4.56 Bn 221.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 140,000.00
Jun 30, 2024 82,000.00
Dec 31, 2023 25,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 3,000.00
Mar 31, 2023 630,000.00
Dec 31, 2022 30,000.00
Sep 30, 2022 13,000.00
Jun 30, 2022 17,000.00
Mar 31, 2022 131,000.00
Dec 31, 2021 154,000.00
Sep 30, 2021 349,000.00
Jun 30, 2021 103,000.00
Mar 31, 2021 4.50 Mn
Dec 31, 2020 3.84 Mn
Sep 30, 2020 2.41 Mn
Jun 30, 2020 310,000.00
Mar 31, 2020 208,000.00
Dec 31, 2019 -91,000.00
Sep 30, 2019 265,000.00
API Access

Travere Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TVTX&period=max&api_key=YOUR_API_KEY